AHCL Share Price Performance
₹126.84
35.11 (38.28%)
Price ₹126.84
Share Price₹126.84
Anlon Healthcare Limited Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
AHCL Community Narratives
There are no narratives available yet.
Recent AHCL News & Updates
No updates
Anlon Healthcare Limited Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 3.86
- Gross Margin
- 37.49%
- Net Profit Margin
- 17.05%
- Debt/Equity Ratio
- 82.8%
Anlon Healthcare Limited Competitors
Snowflake Analysis
About AHCL
- Founded
- 2013
- Employees
- 117
- CEO
- WebsiteView website
Anlon Healthcare Limited manufactures and sells advance pharmaceutical intermediates in India and internationally. The company offers active pharmaceutical ingredients (API); nutraceutical API products; personal care ingredients; and veterinary API products. Its products are used in anti-inflammatory (NSAID), analgesic, antipyretic, antihistamine, antidepressant, antipsychotic, anticoagulant, antihypertensive, nutrition, anti-arrhythmic, anti-hyper parathyroid, antiplatelet, ant diabetic, gastroesophageal reflux disease (GERD), and anti-rheumatic therapeutics areas. The company was incorporated in 2013 and is based in Rajkot, India.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Indian Market Performance
- 7 Days: 1.5%
- 3 Months: -1.7%
- 1 Year: -4.7%
- Year to Date: 0.7%
The market has climbed 1.5% in the last 7 days, lead by the Financials sector with a gain of 2.3%. In contrast, the market has seen a decline of 4.7% over the last 12 months. Looking forward, earnings are forecast to grow by 16% annually. Market details ›